Financhill
Back

United Therapeutics 10K Form

Buy
59

UTHR
United Therapeutics

Last Price:
376.96
Seasonality Move:
11.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive UTHR News And Ratings

See the #1 stock for the next 7 days that we like better than UTHR

UTHR Financial Statistics

Sales & Book Value

Annual Sales: $2.33B
Cash Flow: $300.7M
Price / Cash Flow: 20.52
Annual Sales: $136.74
Price / Book: 2.76

Profitability

EPS (TTM): 22.77000
Net Income (TTM): $1.11B
Gross Margin: $2.07B
Return on Equity: 19.26%
Return on Assets: 16.09%

United Therapeutics Earnings Forecast

Key United Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 25 years for UTHR is 88.94%.
  • The Selling, General & Administrative Expenses for UTHR have been equal to 20.50% of Gross Profit Margin.
  • The Research & Development expenses have been 17.53% of Revenue.
  • The Interest Expense is 6.02% of Operating Income.
  • The Net Earning history of UTHR is 42.31% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 17 years.

United Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: UTHR
CUSIP: 91307C
Website: unither.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 4.58
Quick Ratio: 4.2

Price-to-Earnings

Trailing P/E Ratio: 19.02
Forward P/E Ratio: 13.13

UTHR Technical Analysis vs Fundamental Analysis

Buy
59
United Therapeutics (UTHR) is a Buy

Is United Therapeutics a Buy or a Sell?